Related Experiment Video
Updated: Jul 28, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Difficult cases in heart failure: Role of continuous ambulatory peritoneal dialysis in refractory heart failure
L S Parvathaneni1, K Gugleilmi, M A Silver
1Heart Failure Institute and the Department of Medicine, Sections of Cardiology and Renal Diseases, Christ Hospital and Medical Center, Oaklawn, IL 60453.
Insights
Continuous ambulatory peritoneal dialysis (CAPD) effectively manages refractory congestive heart failure (CHF) by safely removing excess fluid. This treatment modality offers prolonged medical improvement for patients with biventricular failure and comorbidities.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Refractory congestive heart failure (CHF) presents significant management challenges.
- Peritoneal dialysis has been explored for heart failure treatment.
- Advances in understanding physiology and technique enable prolonged use of peritoneal dialysis.
Purpose of the Study:
- To evaluate continuous ambulatory peritoneal dialysis (CAPD) as a treatment for refractory CHF.
- To assess the safety and efficacy of CAPD in cardiac patients with comorbidities.
- To explore CAPD as an alternative for patients unresponsive to maximal medical management.
Main Methods:
- Case report of two patients with NYHA Class IV heart failure.
- Patients unresponsive to pharmacological management and developed prerenal dialysis.
- Treatment involved continuous ambulatory peritoneal dialysis (CAPD).
Main Results:
- Both patients remained on CAPD for 6 months without significant complications.
- Patients showed improvement from NYHA Class IV to NYHA Class I.
- CAPD effectively removed fluid volume, contributing to medical improvement.
Conclusions:
- CAPD is a viable and effective treatment modality for refractory CHF.
- Consider CAPD for biventricular failure patients with pulmonary hypertension and renal insufficiency.
- CAPD offers a safe and effective option for prolonged medical improvement in select cardiac patients.
Abstract:
Continuous ambulatory peritoneal dialysis (CAPD) offers a new modality for use in the treatment of refractory congestive heart failure (CHF). Although the use of peritoneal dialysis to treat refractory heart failure is not new, improved understanding of the physiology and technique of this system has allowed its use over prolonged periods of time. The application of continuous peritoneal dialysis to the cardiac patient changes its scope considerably. When combined with current medical treatment, it removes fluid volume effectively and safely providing the best possibility for prolonged medical improvement. Continuous ambulatory peritoneal dialysis should be considered in patients with biventricular failure who have associated comorbidities like pulmonary hypertension and progressive renal insufficiency. We report the management of two such patients with NYHA Class IV heart failure who had become unresponsive to maximum pharmacological management and developed prerenal dialysis and during the 6 month follow up remained on dialysis without developing any significant complications and improved to NYHA class I. (c)1999 by CHF, Inc.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Heart Failure VI: Adjunct Therapies
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Continuous Renal Replacement Therapy

